These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28217105)

  • 21. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis, or axial dystonia).
    Marsden CD
    Adv Neurol; 1976; 14():259-76. PubMed ID: 941774
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of primary focal dystonias in the western area of Tottori prefecture in Japan: Comparison with prevalence evaluated in 1993.
    Fukuda H; Kusumi M; Nakashima K
    Mov Disord; 2006 Sep; 21(9):1503-6. PubMed ID: 16755586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A genetic study of idiopathic focal dystonias.
    Stojanović M; Cvetković D; Kostić VS
    J Neurol; 1995 Aug; 242(8):508-11. PubMed ID: 8530978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin.
    Van den Bergh P; Francart J; Mourin S; Kollmann P; Laterre EC
    Muscle Nerve; 1995 Jul; 18(7):720-9. PubMed ID: 7783762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From writer's cramp to butcher's spasms: a case of interprofessional dystonia].
    Requena I; Lema C; Arias M
    Rev Neurol; 1998 Sep; 27(157):513-4. PubMed ID: 9774831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus statement for the management of focal dystonias.
    Williams A
    Br J Hosp Med; 1993 Dec 15-1994 Jan 18; 50(11):655-9. PubMed ID: 8124547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic Lesioning of the Thalamic Vo Nucleus for the Treatment of Writer's Cramp (Focal Hand Dystonia).
    Shimizu T; Maruo T; Miura S; Kishima H; Ushio Y; Goto S
    Front Neurol; 2018; 9():1008. PubMed ID: 30534112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Writer's cramp: is focal dystonia the best explanation?
    Pritchard MH
    JRSM Short Rep; 2013 Jul; 4(7):1-7. PubMed ID: 23885297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How psychogenic is dystonia? Views from past to present.
    Munts AG; Koehler PJ
    Brain; 2010 May; 133(Pt 5):1552-64. PubMed ID: 20350935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites.
    Logroscino G; Livrea P; Anaclerio D; Aniello MS; Benedetto G; Cazzato G; Giampietro L; Manobianca G; Marra M; Martino D; Pannarale P; Pulimeno R; Santamato V; Defazio G
    J Neurol Neurosurg Psychiatry; 2003 Mar; 74(3):348-50. PubMed ID: 12588923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonia.
    Ryuji K
    Handb Clin Neurol; 2013; 116():485-9. PubMed ID: 24112917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expert recommendations for diagnosing cervical, oromandibular, and limb dystonia.
    Defazio G; Albanese A; Pellicciari R; Scaglione CL; Esposito M; Morgante F; Abbruzzese G; Bentivoglio AR; Bono F; Coletti Moja M; Fabbrini G; Girlanda P; Lopiano L; Pacchetti C; Romano M; Fadda L; Berardelli A
    Neurol Sci; 2019 Jan; 40(1):89-95. PubMed ID: 30269178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary focal dystonia: descriptive study of 205 patients].
    Bartolomé FM; Fanjul S; Cantarero S; Hernández J; García Ruiz PJ
    Neurologia; 2003 Mar; 18(2):59-65. PubMed ID: 12610754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality of life in patients with focal dystonia.
    Pekmezovic T; Svetel M; Ivanovic N; Dragasevic N; Petrovic I; Tepavcevic DK; Kostic VS
    Clin Neurol Neurosurg; 2009 Feb; 111(2):161-4. PubMed ID: 18995953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Writer's cramp--a focal dystonia: etiology, diagnosis, and treatment.
    Rhoad RC; Stern PJ
    J Hand Surg Am; 1993 May; 18(3):541-4. PubMed ID: 8515033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.